Results 131 to 140 of about 1,198,781 (288)

HISEC: a new lightweight block cipher algorithm

open access: yes, 2014
Lightweight block cipher algorithms are vital for constrained environment. There are many applications need secured lightweight block cipher algorithm like credit card, E-passport and etc.
Alshaikhli, Imad Fakhri Taha   +2 more
core  

Algebraic Properties of the Block Cipher DESL

open access: yes, 2019
The Data Encryption Standard Lightweight extension (DESL) is a lightweight block cipher which is very similar to DES, but unlike DES uses only a single S-box.
Adriana Suárez Corona   +2 more
core   +1 more source

Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba   +5 more
wiley   +1 more source

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

open access: yesMolecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David   +12 more
wiley   +1 more source

Enhancement of lightweight block cipher algorithms

open access: yes, 2017
This research dealt with three problems; First, it is difficult to optimized three factors at same time. Second, there are many researches still trying to find an algorithm that has the highest level of security.
Zaba, Muhammad Reza   +2 more
core  

WCFB: a tweakable wide block cipher [PDF]

open access: yes, 2014
We define a model for applications that process large data sets in a way that enables additional optimizations of encryption operations. We designed a new strong pseudo-random tweakable permutation, WCFB, to take advantage of identified characteristics ...
Andrey Jivsov
core  

Reprogramming tumor cells with LCOR mRNA nanotherapy to enhance immunotherapy

open access: yesMolecular Oncology, EarlyView.
LCOR (Ligand‐dependent corepressor) mRNA encapsulated in polymeric nanoparticles restores LCOR activity in tumor cells, constraining aggressive tumor cell states and increasing tumor immunogenicity. This reprogramming makes tumor cells more vulnerable to T‐cell attack and enhances their response to immune‐checkpoint immunotherapy.
Gabriel Serra‐Mir   +9 more
wiley   +1 more source

FPGA Modeling and Optimization of a SIMON Lightweight Block Cipher. [PDF]

open access: yesSensors (Basel), 2019
Abed S, Jaffal R, Mohd BJ, Alshayeji M.
europepmc   +1 more source

Optimization of seminal extracellular vesicle isolation protocols for cancer biomarker analysis using proteomic profiling

open access: yesMolecular Oncology, EarlyView.
This paper shows that size‐exclusion chromatography and sequential centrifugation applied to seminal plasma enrich for different populations of extracellular vesicles. This may significantly affect the detection and analysis of extracellular vesicle‐associated cancer biomarkers.
Elen Telumyan   +8 more
wiley   +1 more source

USP7 inhibits FOXO1 activity in chronic lymphocytic leukaemia cells enhancing cell survival

open access: yesMolecular Oncology, EarlyView.
CLL cells rely on BCR‐mediated signalling for survival and proliferation in part through suppression of FOXO1. FOXO1 activity is regulated by a plethora of post‐translational modifications including phosphorylation and ubiquitination. We demonstrated that dual inhibition of BCR signalling and the deubiquitinase USP7 activates FOXO1, modulating its ...
Hassan N.B. Almuhanna   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy